Fact CheckerSign in

NCT06730139Completed

Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment

Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment: a Cross Sectional Study in Egypt

Source: ClinicalTrials.gov · Last updated 12 Dec 2024

Brief summary (registry, in English)

Oral Health-Related Quality of Life in Head and Neck Cancer Patients Problem Statement: Head and Neck Cancer (HNC) is a significant global health issue, and its incidence is rising. While treatment options have improved, they often lead to severe oral complications, impacting patients' quality of life. Research Gap: Limited research exists on oral health-related quality of life (OHRQoL) among HNC patients in Egypt, particularly focusing on the impact of oral clinical parameters and treatment-related factors. Research Objective: To assess the OHRQoL of HNC patients who have completed treatment within the past 12 months and to identify factors associated with impaired OHRQoL. Methodology: This study will employ a comprehensive approach to evaluate OHRQoL, considering: Oral Clinical Parameters: Oral hygiene status, oral mucositis, and other oral health indicators. Sociodemographic Factors: Age, gender, education, occupation, and socioeconomic status. Treatment-Related Variables: Type of treatment (surgery, radiation therapy, chemotherapy), treatment duration, and dose intensity. Expected Outcomes: The findings of this study will: Quantify the impact of HNC treatment on OHRQoL. Identify key factors associated with impaired OHRQoL. Highlight the importance of standardized oral care for HNC patients. Provide evidence-based recommendations for improving oral health support and enhancing the overall quality of life for HNC survivors. By addressing the oral health needs of HNC patients, this research aims to improve their quality of life and contribute to better long-term outcomes.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
6 Dec 2024
Start date
20 Dec 2023
Primary completion date
20 Aug 2024
Lead sponsor
Ain Shams University
NCT number
NCT06730139

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 20 Dec 2023 to the primary completion date, 20 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Debilitative conditions or cognitive disabilities

Other

  • Inability to provide informed consent
  • Trismus (mouth opening \< 20 mm)

Who the study is looking for

  • Age 18 years and above
  • Diagnosed with HNC
  • Within the first year post-cancer treatment
  • Scheduled for a routine follow-up visit at AMTH
  • Presence of at least one molar and one central incisor in each jaw
  • Able to provide informed consent

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ahmed Maher Teaching Hospital
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.